HealthcareServices

Hepatitis C Testing Market Performance Outlook 2026–2030: Revenue to Hit $1.77 Billion at 6.1% CAGR

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the hepatitis c testing market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Hepatitis C Testing Market between 2026 and 2030?

The hepatitis c testing market has experienced robust growth recently. Forecasts indicate it will expand from $1.32 billion in 2025 to $1.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. Historically, this expansion is linked to factors such as broader blood screening programs, an increase in the prevalence of hepatitis c infections, enhanced awareness regarding diagnostics, the introduction of advanced testing kits, and an uptick in public health surveillance efforts.

The hepatitis c testing market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $1.78 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. Several factors are driving this growth during the forecast period, including a rise in global elimination programs, increased demand for point-of-care diagnostic tools, broader availability of molecular testing, greater investment in diagnostics for infectious diseases, and a heightened emphasis on early intervention strategies. Key trends expected during this period involve a greater embrace of rapid diagnostic tests, an uptick in the application of molecular testing technologies, a reinforced commitment to early disease screening, an increase in high-throughput laboratory testing capabilities, and improved oversight of treatment results.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Hepatitis C Testing Market?

The increasing occurrence of hepatitis cases is projected to drive expansion in the hepatitis C testing market. Hepatitis C, a viral infection, inflames the liver and, if unaddressed, can result in severe liver damage. The rise in hepatitis cases is primarily due to inadequate vaccination coverage, leaving many vulnerable and aiding viral transmission. Early detection of the virus through hepatitis C testing enables timely treatment, preventing liver damage and major complications. Furthermore, it identifies infected people, helping to stop its spread and improve disease management. For instance, the World Health Organization (WHO), a Switzerland-based intergovernmental organization focused on global public health, reported in April 2024 that globally over 50 million people live with chronic hepatitis C virus infection, with about 1.0 million new infections annually. Consequently, the growing occurrence of hepatitis cases is propelling the hepatitis C testing market’s expansion.

What Segments Are Included Within The Hepatitis C Testing Market?

The hepatitis c testing market covered in this report is segmented –

1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

Subsegments:

1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

What Trends Are Expected To Impact The Competitive Landscape Of The Hepatitis C Testing Market?

Major companies in the hepatitis C testing market are prioritizing the development of advanced solutions like dual antigen-antibody diagnostic tests to facilitate more effective screening and monitoring of the infection. An antigen-antibody diagnostic test works by identifying viral proteins (antigens) and immune response proteins (antibodies), thereby distinguishing both active and past infections. This combined approach delivers a comprehensive assessment of the infection status. For example, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based supplier of diagnostic tests and systems, introduced Elecsys HCV Duo, a fully automated immunoassay capable of detecting both HCV antigens and antibodies simultaneously and independently from a single plasma or serum sample. This innovation aids in early diagnosis, improves patient management, and aligns with India’s national strategy for hepatitis C elimination through prompt and thorough screening.

Who Are The Top-Performing Companies In The Hepatitis C Testing Market In Recent Years?

Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

How Does The Hepatitis C Testing Market Perform Across Major Global Regions?

North America was the largest region in the hepatitis C testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hepatitis C Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2026, By The Business Research Company

Viral Hepatitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Hepatitis Diagnostic Tests Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Covid 19 Rapid Test Kits Market Report 2026

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795